Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Hepatocellular response in Cholestatic Liver Diseases. | Organogenesis | 2023 | 37598346 | PubTator, text mining | PubMed |
| Artificial intelligence-based approaches for the detection and prioritization of genomic mutations in congenital surgical diseases. | Front Pediatr | 2023 | 37593442 | PubTator, text mining | PubMed |
| ABCB4 gene mutation-associated cirrhosis with systemic amyloidosis: A case report. | World J Clin Cases | 2023 | 37584002 | PubTator, text mining | PubMed |
| LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles. | Acta Pharmacol Sin | 2023 | 37580495 | PubTator, text mining | PubMed |
| Inhibiting Wnt Signaling Reduces Cholestatic Injury by Disrupting the Inflammatory Axis. | Cell Mol Gastroenterol Hepatol | 2023 | 37579970 | PubTator, text mining | PubMed |
| Current Therapeutics in Primary Sclerosing Cholangitis. | J Clin Transl Hepatol | 2023 | 37577219 | PubTator, text mining | PubMed |
| Variable Intrafamilial Expression of ABCB4 Disease. | ACG Case Rep J | 2023 | 37575491 | PubTator, text mining | PubMed |
| GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2-/- Mice Via Activation of NR4a1/Nur77 in Hepatic Stellate Cells and Intestinal FXR Signaling. | Cell Mol Gastroenterol Hepatol | 2023 | 37572734 | PubTator, text mining | PubMed |
| Advancing diagnosis and management of liver disease in adults through exome sequencing. | EBioMedicine | 2023 | 37566928 | PubTator, text mining | PubMed |
| Pediatric Residents' Perceptions of a Point-of-Care Ultrasound Collaboration With Emergency Medicine. | Cureus | 2023 | 37565129 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health. | PLoS One | 2023 | 37556419 | PubTator, text mining | PubMed |
| [Efficacy and safefy of Polymyxin B treatment for neutropenic patients suffering from refractory Gram-negative bacterial bloodstream infection]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550204 | PubTator, text mining | PubMed |
| Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients? | Hepat Med | 2023 | 37547355 | PubTator, text mining | PubMed |
| Revisited role of the placenta in bile acid homeostasis. | Front Physiol | 2023 | 37546542 | PubTator, text mining | PubMed |
| Development of a human iPSC-derived placental barrier-on-chip model. | iScience | 2023 | 37534160 | PubTator, text mining | PubMed |
| Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center. | Int J Hepatol | 2023 | 37520499 | PubTator, text mining | PubMed |
| Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy. | Pharmaceutics | 2023 | 37514148 | PubTator, text mining | PubMed |
| Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis. | J Pers Med | 2023 | 37511794 | PubTator, text mining | PubMed |
| Characterization of the two tandem repeats for the KPC-2 core structures on a plasmid from hospital-derived Klebsiella pneumoniae. | Sci Rep | 2023 | 37491538 | PubTator, text mining | PubMed |
| Sample representativeness and influence of attrition on longitudinal data collected as part of a national medical career tracking project. | BMC Med Educ | 2023 | 37491266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=13